Chemokine regulation of neutrophil function in tumors

Cytokine and Growth Factor Reviews

Volumn 30, Issue , 2016, Pages 81-86

  Bonavita, Ornella ^a,b   Massara, Matteo ^a,b   Bonecchi, Raffaella ^a,c  

^a HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c HUMANITAS UNIVERSITY   (Italy)

Author keywords

Cancer; Chemokines; Inflammation; Neutrophils

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR CXCR1; CHEMOKINE RECEPTOR CXCR2; CHEMOKINE RECEPTOR CXCR4; CXCL1 CHEMOKINE; CXCL2 CHEMOKINE; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; GRANULOCYTE CHEMOTACTIC PROTEIN 2; INTERLEUKIN 8;

CARCINOGENESIS; CELL ACTIVITY; CELL FUNCTION; CELL POLARITY; CELL SUBPOPULATION; HUMAN; NEOPLASM; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SHORT SURVEY; ANIMAL; CELL PLASTICITY; IMMUNOLOGY; PHYSIOLOGY;

ANIMALS; CELL PLASTICITY; CHEMOKINES; HUMANS; NEOPLASMS; NEUTROPHIL INFILTRATION; NEUTROPHILS;

EID: 84961807618     PISSN: 13596101     EISSN: 18790305     Source Type: Journal    
DOI: 10.1016/j.cytogfr.2016.03.012     Document Type: Short Survey

References (69)

1. [1] Mantovani, A., Cassatella, M.A., Costantini, C., Jaillon, S., Neutrophils in the activation and regulation of innate and adaptive immunity. Nat. Rev. Immunol. 11 (2011), 519–531.
2. [2] Piccard, H., Muschel, R.J., Opdenakker, G., On the dual roles and polarized phenotypes of neutrophils in tumor development and progression. Crit. Rev. Oncol. Hematol. 82 (2012), 296–309.
3. [3] Powell, D.R., Huttenlocher, A., Neutrophils in the tumor microenvironment. Trends Immunol. 37 (2016), 41–52.
4. [4] Shen, M., Hu, P., Donskov, F., Wang, G., Liu, Q., Du, J., Tumor-associated neutrophils as a new prognostic factor in cancer: a systematic review and meta-analysis. PLoS One, 9, 2014, e98259.
5. [5] Templeton, A.J., McNamara, M.G., Seruga, B., Vera-Badillo, F.E., Aneja, P., Ocana, A., et al. Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J. Natl. Cancer Inst., 106, 2014, dju124.
6. [6] Sionov, R.V., Fridlender, Z.G., Granot, Z., The multifaceted roles neutrophils play in the tumor microenvironment. Cancer Microenviron. 8 (2015), 125–158.
7. [7] Liang, W., Ferrara, N., The complex role of neutrophils in tumor angiogenesis and metastasis. Cancer Immunol. Res. 4 (2016), 83–91.
8. [8] Dumitru, C.A., Lang, S., Brandau, S., Modulation of neutrophil granulocytes in the tumor microenvironment: mechanisms and consequences for tumor progression. Semin. Cancer Biol. 23 (2013), 141–148.
9. [9] Wislez, M., Rabbe, N., Marchal, J., Milleron, B., Crestani, B., Mayaud, C., et al. Hepatocyte growth factor production by neutrophils infiltrating bronchioloalveolar subtype pulmonary adenocarcinoma: role in tumor progression and death. Cancer Res. 63 (2003), 1405–1412.
10. [10] Nozawa, H., Chiu, C., Hanahan, D., Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis. Proc. Natl. Acad. Sci. U. S. A. 103 (2006), 12493–12498.
11. [11] Queen, M.M., Ryan, R.E., Holzer, R.G., Keller-Peck, C.R., Jorcyk, C.L., Breast cancer cells stimulate neutrophils to produce oncostatin M: potential implications for tumor progression. Cancer Res. 65 (2005), 8896–8904.
12. [12] Tazawa, H., Okada, F., Kobayashi, T., Tada, M., Mori, Y., Une, Y., et al. Infiltration of neutrophils is required for acquisition of metastatic phenotype of benign murine fibrosarcoma cells: implication of inflammation-associated carcinogenesis and tumor progression. Am. J. Pathol. 163 (2003), 2221–2232.
13. [13] Ruan, D., So, S.P., Prostaglandin E2 produced by inducible COX-2 and mPGES-1 promoting cancer cell proliferation in vitro and in vivo. Life Sci. 116 (2014), 43–50.
14. [14] Houghton, A.M., Rzymkiewicz, D.M., Ji, H., Gregory, A.D., Egea, E.E., Metz, H.E., et al. Neutrophil elastase-mediated degradation of IRS-1 accelerates lung tumor growth. Nat. Med. 16 (2010), 219–223.
15. [15] Wculek, S.K., Malanchi, I., Neutrophils support lung colonization of metastasis-initiating breast cancer cells. Nature 528 (2015), 413–417.
16. [16] Cools-Lartigue, J., Spicer, J., McDonald, B., Gowing, S., Chow, S., Giannias, B., et al. Neutrophil extracellular traps sequester circulating tumor cells and promote metastasis. J. Clin. Invest., 2013.
17. [17] Rotondo, R., Barisione, G., Mastracci, L., Grossi, F., Orengo, A.M., Costa, R., et al. IL-8 induces exocytosis of arginase 1 by neutrophil polymorphonuclears in nonsmall cell lung cancer. Int. J. Cancer 125 (2009), 887–893.
18. [18] He, G., Zhang, H., Zhou, J., Wang, B., Chen, Y., Kong, Y., et al. Peritumoural neutrophils negatively regulate adaptive immunity via the PD-L1/PD-1 signalling pathway in hepatocellular carcinoma. J. Exp. Clin. Cancer Res., 34, 2015, 141.
19. [19] Aoyagi, Y., Oda, T., Kinoshita, T., Nakahashi, C., Hasebe, T., Ohkohchi, N., et al. Overexpression of TGF-beta by infiltrated granulocytes correlates with the expression of collagen mRNA in pancreatic cancer. Br. J. Cancer 91 (2004), 1316–1326.
20. [20] Tecchio, C., Micheletti, A., Cassatella, M.A., Neutrophil-derived cytokines: facts beyond expression. Front. Immunol., 5, 2014, 508.
21. [21] Lichtenstein, A., Berenson, J., Norman, D., Chang, M.P., Carlile, A., Production of cytokines by bone marrow cells obtained from patients with multiple myeloma. Blood 74 (1989), 1266–1273.
22. [22] Yan, J., Kloecker, G., Fleming, C., Bousamra 2nd, M., Hansen, R., Hu, X., et al. Human polymorphonuclear neutrophils specifically recognize and kill cancerous cells. Oncoimmunology, 3, 2014, e950163.
23. [23] Granot, Z., Henke, E., Comen, E.A., King, T.A., Norton, L., Benezra, R., Tumor entrained neutrophils inhibit seeding in the premetastatic lung. Cancer Cell 20 (2011), 300–314.
24. [24] Stoppacciaro, A., Melani, C., Parenza, M., Mastracchio, A., Bassi, C., Baroni, C., et al. Regression of an established tumor genetically modified to release granulocyte colony-stimulating factor requires granulocyte-T cell cooperation and T cell-produced interferon gamma. J. Exp. Med. 178 (1993), 151–161.
25. [25] Brandsma, A.M., Ten Broeke, T., Nederend, M., Meulenbroek, L.A., van Tetering, G., Meyer, S., et al. Simultaneous targeting of FcgammaRs and FcalphaRI enhances tumor cell killing. Cancer Immunol. Res. 3 (2015), 1316–1324.
26. [26] Cassatella, M.A., Huber, V., Calzetti, F., Margotto, D., Tamassia, N., Peri, G., et al. Interferon-activated neutrophils store a TNF-related apoptosis-inducing ligand (TRAIL/Apo-2 ligand) intracellular pool that is readily mobilizable following exposure to proinflammatory mediators. J. Leukoc. Biol. 79 (2006), 123–132.
27. [27] Kemp, T.J., Ludwig, A.T., Earel, J.K., Moore, J.M., Vanoosten, R.L., Moses, B., et al. Neutrophil stimulation with Mycobacterium bovis bacillus Calmette-Guerin (BCG) results in the release of functional soluble TRAIL/Apo-2L. Blood 106 (2005), 3474–3482.
28. [28] Chen, Y.L., Chen, S.H., Wang, J.Y., Yang, B.C., Fas ligand on tumor cells mediates inactivation of neutrophils. J. Immunol. 171 (2003), 1183–1191.
29. [29] Eruslanov, E.B., Bhojnagarwala, P.S., Quatromoni, J.G., Stephen, T.L., Ranganathan, A., Deshpande, C., et al. Tumor-associated neutrophils stimulate T cell responses in early-stage human lung cancer. J. Clin. Invest. 124 (2014), 5466–5480.
30. [30] Berger-Achituv, S., Brinkmann, V., Abed, U.A., Kuhn, L.I., Ben-Ezra, J., Elhasid, R., et al. A proposed role for neutrophil extracellular traps in cancer immunoediting. Front. Immunol., 4, 2013, 48.
31. [31] Suttmann, H., Riemensberger, J., Bentien, G., Schmaltz, D., Stockle, M., Jocham, D., et al. Neutrophil granulocytes are required for effective Bacillus Calmette-Guerin immunotherapy of bladder cancer and orchestrate local immune responses. Cancer Res. 66 (2006), 8250–8257.
32. [32] Tsuda, Y., Takahashi, H., Kobayashi, M., Hanafusa, T., Herndon, D.N., Suzuki, F., Three different neutrophil subsets exhibited in mice with different susceptibilities to infection by methicillin-resistant Staphylococcus aureus. Immunity 21 (2004), 215–226.
33. [33] Beyrau, M., Bodkin, J.V., Nourshargh, S., Neutrophil heterogeneity in health and disease: a revitalized avenue in inflammation and immunity. Open Biol., 2, 2012, 120134.
34. [34] Zhang, D., Chen, G., Manwani, D., Mortha, A., Xu, C., Faith, J.J., et al. Neutrophil ageing is regulated by the microbiome. Nature 525 (2015), 528–532.
35. [35] Pillay, J., Ramakers, B.P., Kamp, V.M., Loi, A.L., Lam, S.W., Hietbrink, F., et al. Functional heterogeneity and differential priming of circulating neutrophils in human experimental endotoxemia. J. Leukoc. Biol. 88 (2010), 211–220.
36. [36] Pillay, J., Kamp, V.M., van Hoffen, E., Visser, T., Tak, T., Lammers, J.W., et al. A subset of neutrophils in human systemic inflammation inhibits T cell responses through Mac-1. J. Clin. Invest. 122 (2012), 327–336.
37. [37] Hao, S., Andersen, M., Yu, H., Detection of immune suppressive neutrophils in peripheral blood samples of cancer patients. Am. J. Blood Res. 3 (2013), 239–245.
38. [38] Buckley, C.D., Ross, E.A., McGettrick, H.M., Osborne, C.E., Haworth, O., Schmutz, C., et al. Identification of a phenotypically and functionally distinct population of long-lived neutrophils in a model of reverse endothelial migration. J. Leukoc. Biol. 79 (2006), 303–311.
39. [39] Woodfin, A., Voisin, M.B., Beyrau, M., Colom, B., Caille, D., Diapouli, F.M., et al. The junctional adhesion molecule JAM-C regulates polarized transendothelial migration of neutrophils in vivo. Nat. Immunol. 12 (2011), 761–769.
40. [40] Mathias, J.R., Perrin, B.J., Liu, T.X., Kanki, J., Look, A.T., Huttenlocher, A., Resolution of inflammation by retrograde chemotaxis of neutrophils in transgenic zebrafish. J. Leukoc. Biol. 80 (2006), 1281–1288.
41. [41] Massena, S., Christoffersson, G., Vagesjo, E., Seignez, C., Gustafsson, K., Binet, F., et al. Identification and characterization of VEGF-A-responsive neutrophils expressing CD49d, VEGFR1, and CXCR4 in mice and humans. Blood 126 (2015), 2016–2026.
42. [42] Sagiv, J.Y., Michaeli, J., Assi, S., Mishalian, I., Kisos, H., Levy, L., et al. Phenotypic diversity and plasticity in circulating neutrophil subpopulations in cancer. Cell Rep. 10 (2015), 562–573.
43. [43] Fridlender, Z.G., Sun, J., Kim, S., Kapoor, V., Cheng, G., Ling, L., et al. Polarization of tumor-associated neutrophil phenotype by TGF-beta: n1 versus N2 TAN. Cancer Cell 16 (2009), 183–194.
44. [44] Andzinski, L., Kasnitz, N., Stahnke, S., Wu, C.F., Gereke, M., von Kockritz-Blickwede, M., et al. Type I. IFNs induce anti-tumor polarization of tumor associated neutrophils in mice and human. Int. J. Cancer 138 (2016), 1982–1993.
45. [45] Finisguerra, V., Di Conza, G., Di Matteo, M., Serneels, J., Costa, S., Thompson, A.A., et al. MET is required for the recruitment of anti-tumoural neutrophils. Nature 522 (2015), 349–353.
46. [46] Jablonska, J., Leschner, S., Westphal, K., Lienenklaus, S., Weiss, S., Neutrophils responsive to endogenous IFN-beta regulate tumor angiogenesis and growth in a mouse tumor model. J. Clin. Invest. 120 (2010), 1151–1164.
47. [47] Mishalian, I., Bayuh, R., Levy, L., Zolotarov, L., Michaeli, J., Fridlender, Z.G., Tumor-associated neutrophils (TAN) develop pro-tumorigenic properties during tumor progression. Cancer Immunol. Immunother. 62 (2013), 1745–1756.
48. [48] Tabaries, S., Ouellet, V., Hsu, B.E., Annis, M.G., Rose, A.A., Meunier, L., et al. Granulocytic immune infiltrates are essential for the efficient formation of breast cancer liver metastases. Breast Cancer Res., 17, 2015, 45.
49. [49] Sparmann, A., Bar-Sagi, D., Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis. Cancer Cell 6 (2004), 447–458.
50. [50] Xie, K., Interleukin-8 and human cancer biology. Cytokine Growth Factor Rev. 12 (2001), 375–391.
51. [51] Sandhu, J.K., Privora, H.F., Wenckebach, G., Birnboim, H.C., Neutrophils, nitric oxide synthase, and mutations in the mutatect murine tumor model. Am. J. Pathol. 156 (2000), 509–518.
52. [52] Park, J.Y., Park, K.H., Bang, S., Kim, M.H., Lee, J.E., Gang, J., et al. CXCL5 overexpression is associated with late stage gastric cancer. J. Cancer Res. Clin. Oncol. 133 (2007), 835–840.
53. [53] Miyazaki, H., Patel, V., Wang, H., Edmunds, R.K., Gutkind, J.S., Yeudall, W.A., Down-regulation of CXCL5 inhibits squamous carcinogenesis. Cancer Res. 66 (2006), 4279–4284.
54. [54] Zhou, S.L., Dai, Z., Zhou, Z.J., Wang, X.Y., Yang, G.H., Wang, Z., et al. Overexpression of CXCL5 mediates neutrophil infiltration and indicates poor prognosis for hepatocellular carcinoma. Hepatology 56 (2012), 2242–2254.
55. [55] Zhou, S.L., Dai, Z., Zhou, Z.J., Chen, Q., Wang, Z., Xiao, Y.S., et al. CXCL5 contributes to tumor metastasis and recurrence of intrahepatic cholangiocarcinoma by recruiting infiltrative intratumoral neutrophils. Carcinogenesis 35 (2014), 597–605.
56. [56] Van Coillie, E., Van Aelst, I., Wuyts, A., Vercauteren, R., Devos, R., De Wolf-Peeters, C., et al. Tumor angiogenesis induced by granulocyte chemotactic protein-2 as a countercurrent principle. Am. J. Pathol. 159 (2001), 1405–1414.
57. [57] Verbeke, H., Struyf, S., Berghmans, N., Van Coillie, E., Opdenakker, G., Uyttenhove, C., et al. Isotypic neutralizing antibodies against mouse GCP-2/CXCL6 inhibit melanoma growth and metastasis. Cancer Lett. 302 (2011), 54–62.
58. [58] Acharyya, S., Oskarsson, T., Vanharanta, S., Malladi, S., Kim, J., Morris, P.G., et al. A CXCL1 paracrine network links cancer chemoresistance and metastasis. Cell 150 (2012), 165–178.
59. [59] Jablonska, J., Wu, C.F., Andzinski, L., Leschner, S., Weiss, S., CXCR2-mediated tumor-associated neutrophil recruitment is regulated by IFN-beta. Int. J. Cancer 134 (2014), 1346–1358.
60. [60] Lopez-Lago, M.A., Posner, S., Thodima, V.J., Molina, A.M., Motzer, R.J., Chaganti, R.S., Neutrophil chemokines secreted by tumor cells mount a lung antimetastatic response during renal cell carcinoma progression. Oncogene 32 (2013), 1752–1760.
61. [61] Nagase, H., Miyamasu, M., Yamaguchi, M., Imanishi, M., Tsuno, N.H., Matsushima, K., et al. Cytokine-mediated regulation of CXCR4 expression in human neutrophils. J. Leukoc. Biol. 71 (2002), 711–717.
62. [62] Martin, C., Burdon, P.C., Bridger, G., Gutierrez-Ramos, J.C., Williams, T.J., Rankin, S.M., Chemokines acting via CXCR2 and CXCR4 control the release of neutrophils from the bone marrow and their return following senescence. Immunity 19 (2003), 583–593.
63. [63] Chen, Y., Ramjiawan, R.R., Reiberger, T., Ng, M.R., Hato, T., Huang, Y., et al. CXCR4 inhibition in tumor microenvironment facilitates anti-programmed death receptor-1 immunotherapy in sorafenib-treated hepatocellular carcinoma in mice. Hepatology 61 (2015), 1591–1602.
64. [64] Hartl, D., Krauss-Etschmann, S., Koller, B., Hordijk, P.L., Kuijpers, T.W., Hoffmann, F., et al. Infiltrated neutrophils acquire novel chemokine receptor expression and chemokine responsiveness in chronic inflammatory lung diseases. J. Immunol. 181 (2008), 8053–8067.
65. [65] Bonecchi, R., Facchetti, F., Dusi, S., Luini, W., Lissandrini, D., Simmelink, M., et al. Induction of functional IL-8 receptors by IL-4 and IL-13 in human monocytes. J. Immunol. 164 (2000), 3862–3869.
66. [66] Fujimura, N., Xu, B., Dalman, J., Deng, H., Aoyama, K., Dalman, R.L., CCR2 inhibition sequesters multiple subsets of leukocytes in the bone marrow. Sci. Rep., 5, 2015, 11664.
67. [67] Talbot, J., Bianchini, F.J., Nascimento, D.C., Oliveira, R.D., Souto, F.O., Pinto, L.G., et al. CCR2 expression in neutrophils plays a critical role in their migration into the joints in rheumatoid arthritis. Arthritis Rheumatol. 67 (2015), 1751–1759.
68. [68] Robertson, A.L., Holmes, G.R., Bojarczuk, A.N., Burgon, J., Loynes, C.A., Chimen, M., et al. A zebrafish compound screen reveals modulation of neutrophil reverse migration as an anti-inflammatory mechanism. Sci. Transl. Med., 6, 2014, 225ra29.
69. [69] Li, B., Allendorf, D.J., Hansen, R., Marroquin, J., Cramer, D.E., Harris, C.L., et al. Combined yeast {beta}-glucan and antitumor monoclonal antibody therapy requires C5a-mediated neutrophil chemotaxis via regulation of decay-accelerating factor CD55. Cancer Res. 67 (2007), 7421–7430.